Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients (VTEH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02213978
Recruitment Status : Recruiting
First Posted : August 12, 2014
Last Update Posted : February 12, 2019
Sponsor:
Information provided by (Responsible Party):
Xiao Tang, Beijing Chao Yang Hospital

Brief Summary:
The purpose of this study is to analyze the effect of the prophylaxis of venous thromboembolism in the critical ill patients, and at the same time, to find out the risk of venous thromboembolism and hemorrhage events occurred under the prophylaxis.

Condition or disease
Venous Thromboembolism Hemorrhage

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2 Weeks
Official Title: A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
Study Start Date : November 2014
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding




Primary Outcome Measures :
  1. the incidence of venous thromboembolism under the thromboprophylaxis in critical ill patients [ Time Frame: 2 weeks ]
    at the same time, to analyze the risk factor of the occurrence of venous thromboembolism despite of thromboprophylaxis


Secondary Outcome Measures :
  1. the incidence of bleeding events under thromboprophylaxis in critical ill patients [ Time Frame: 2 weeks ]
    at the same time, to analyze the risk factors of bleeding in critical ill patients who receive thromboprophylaxis


Other Outcome Measures:
  1. the incidence of venous thromboembolism under the mechanical thromboprophylaxis in the critical ill patients who with the contraindications to anticoagulation [ Time Frame: 2 weeks ]

    At the same time,to analyze the aspects below:

    1. Evaluation the tolerance to mechanical thromboprophylaxis of these patients
    2. Comparison of the effectiveness between intermittent pneumatic compression and graduated compression stockings in mechanical thromboprophylaxis



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
the critical ill patients in ICUs
Criteria

Inclusion Criteria:

  • all the patients in ICUs estimated time in ICU mare than 48h

Exclusion Criteria:

  • estimated time in ICU less than 48h refused to attend

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02213978


Contacts
Layout table for location contacts
Contact: Bing Sun, MD +86013911151075 ricusunbing@126.com
Contact: Xiao Tang, MD +86013811089795 tangxiao0928@163.com

Locations
Layout table for location information
China, Beijing
Department of respiratory and critical care medicine,Beijing Chao-yang Hospital Recruiting
Beijing, Beijing, China, 100020
Contact: Bing Sun, MD    86013911151075    ricusunbing@126.com   
Contact: Xiao Tang, MD    86013811089795    tangxiao0928@163.com   
Principal Investigator: Bing Sun, MD         
Sponsors and Collaborators
Beijing Chao Yang Hospital
Investigators
Layout table for investigator information
Principal Investigator: Xiao Tang, MD Beijing Chao-Yang Hospital,China

Additional Information:

Layout table for additonal information
Responsible Party: Xiao Tang, doctor of the department of respiratory and critical care medicine of Beijing Chao Yang Hospital, Beijing Chao Yang Hospital
ClinicalTrials.gov Identifier: NCT02213978     History of Changes
Other Study ID Numbers: ICU-VTE-2014
First Posted: August 12, 2014    Key Record Dates
Last Update Posted: February 12, 2019
Last Verified: February 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Thromboembolism
Venous Thromboembolism
Hemorrhage
Pathologic Processes
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases